159 related articles for article (PubMed ID: 2571205)
1. Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts.
Markmann JF; Jacobson JD; Kiumura H; Choti MA; Hickey WF; Fox IJ; Silvers WK; Barker CF; Naji A
Transplantation; 1989 Sep; 48(3):478-86. PubMed ID: 2571205
[TBL] [Abstract][Full Text] [Related]
2. Long-term culture of islets abrogates cytokine-induced or lymphocyte-induced increase of antigen expression on beta cells.
Kuttler B; Hartmann A; Wanka H
Transplantation; 2002 Aug; 74(4):440-5. PubMed ID: 12352900
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
4. Rat pancreatic islet pretreatment with anti-MHC class II monoclonal antibodies and culture: in vitro MLIC test response does not predict islet allograft survival.
Bretzel RG; Flesch BK; Brennenstuhl G; Greiner I; Hering BJ; Woehrle M; Federlin K
Acta Diabetol; 1993; 30(1):49-56. PubMed ID: 8329731
[TBL] [Abstract][Full Text] [Related]
5. Co-culture of pancreatic islets and allogeneic lymphocytes: alterations of responder and stimulator cells.
Kuttler B; Wanka H; Hahn HJ
Transplantation; 1997 Aug; 64(3):480-9. PubMed ID: 9275116
[TBL] [Abstract][Full Text] [Related]
6. The effect of islet cell culture in vitro at 24 degrees C on graft survival and MHC antigen expression.
Markmann JF; Tomaszewski J; Posselt AM; Levy MM; Woehrle M; Barker CF; Naji A
Transplantation; 1990 Feb; 49(2):272-7. PubMed ID: 2106179
[TBL] [Abstract][Full Text] [Related]
7. Effect of immunodepletion of MHC class II-positive cells from pancreatic islets on generation of cytotoxic T-lymphocytes in mixed islet-lymphocyte coculture.
Stock PG; Ascher NL; Platt JL; Kaufman DB; Chen S; Field MJ; Sutherland DE
Diabetes; 1989 Jan; 38 Suppl 1():157-60. PubMed ID: 2642841
[TBL] [Abstract][Full Text] [Related]
8. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
[TBL] [Abstract][Full Text] [Related]
9. Generation of allospecific cytolytic T-lymphocytes stimulated by pure pancreatic beta-cells in absence of Ia+ dendritic cells.
Stock PG; Meloche M; Ascher NL; Chen S; Bach FH; Sutherland DE
Diabetes; 1989 Jan; 38 Suppl 1():161-4. PubMed ID: 2642843
[TBL] [Abstract][Full Text] [Related]
10. Gamma interferon induces novel expression of Ia antigens by rat pancreatic islet endocrine cells.
Markmann JF; Hickey WF; Kimura H; Woehrle M; Barker CF; Naji A
Pancreas; 1987; 2(3):258-61. PubMed ID: 3114739
[TBL] [Abstract][Full Text] [Related]
11. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
12. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice.
Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment of rat pancreatic islets with MHC I-A monoclonal antibody: in-vitro and in-vivo effects on islet antigenicity.
Flesch BK; Bretzel RG; Otto DA; Ernst-Schlegel M; Federlin K
Horm Metab Res; 1991 Aug; 23(8):357-61. PubMed ID: 1794836
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
15. Modulation of MHC class I antigen decreases pancreatic islet immunogenicity.
Stock PG; Ascher NL; Chen S; Bumgardner GL; Field MJ; Sutherland DE
J Surg Res; 1989 Apr; 46(4):317-21. PubMed ID: 2649742
[TBL] [Abstract][Full Text] [Related]
16. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
17. Role of lymphokine in islet allograft rejection.
Hao LM; Wang Y; Gill RG; La Rosa FG; Talmage DW; Lafferty KJ
Transplantation; 1990 Mar; 49(3):609-14. PubMed ID: 1969186
[TBL] [Abstract][Full Text] [Related]
18. Effect of lymphokine-induced MHC antigen expression on islet allograft survival.
Markmann JF; Bassiri HF; Barker CF; Naji A
Transplant Proc; 1989 Feb; 21(1 Pt 3):2723-4. PubMed ID: 2495681
[No Abstract] [Full Text] [Related]
19. Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice.
Formby B; Miller N
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2438-42. PubMed ID: 2138777
[TBL] [Abstract][Full Text] [Related]
20. Antigen presenting function of class II MHC expressing pancreatic beta cells.
Markmann J; Lo D; Naji A; Palmiter RD; Brinster RL; Heber-Katz E
Nature; 1988 Dec; 336(6198):476-9. PubMed ID: 3143077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
